Nivolumab (anti-PD-1)
£579.00
Nivolumab (anti-PD-1) (A2002-5mg)
Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.
View Data Sheet
Product
| Cat # A2002-5mg | Size 5mg |
Price
£579.00
|
Qty
|
Description
Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.
Specifications
| Product Size | 5mg |
|---|---|
| Manufacturer Cat# | A2002 |